Arteris, Inc. (NASDAQ:AIP) COO Laurent R. Moll Sells 4,703 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) COO Laurent R. Moll sold 4,703 shares of the firm’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total value of $33,485.36. Following the completion of the transaction, the chief operating officer now directly owns 482,833 shares in the company, valued at $3,437,770.96. This trade represents a 0.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Arteris Stock Down 9.2 %

Shares of Arteris stock opened at $5.99 on Friday. Arteris, Inc. has a 1-year low of $5.76 and a 1-year high of $12.64. The company has a market capitalization of $245.28 million, a PE ratio of -6.88 and a beta of 1.21. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.17 and a quick ratio of 1.17. The business has a 50-day moving average of $8.70 and a 200-day moving average of $8.78.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. The business had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. As a group, equities analysts forecast that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AIP has been the subject of a number of recent research reports. Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Tuesday, February 18th. Northland Securities increased their price objective on shares of Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Wednesday, February 19th.

Read Our Latest Analysis on AIP

Institutional Trading of Arteris

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Needham Investment Management LLC boosted its stake in Arteris by 0.4% during the 4th quarter. Needham Investment Management LLC now owns 2,745,000 shares of the company’s stock valued at $27,972,000 after acquiring an additional 10,000 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Arteris by 0.8% in the 3rd quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company’s stock valued at $11,201,000 after purchasing an additional 12,375 shares in the last quarter. Samjo Management LLC lifted its position in shares of Arteris by 0.9% during the fourth quarter. Samjo Management LLC now owns 1,157,250 shares of the company’s stock worth $11,792,000 after purchasing an additional 10,000 shares during the last quarter. Geode Capital Management LLC grew its stake in Arteris by 6.6% in the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company’s stock worth $4,610,000 after purchasing an additional 36,908 shares in the last quarter. Finally, State Street Corp increased its holdings in Arteris by 18.5% in the third quarter. State Street Corp now owns 410,578 shares of the company’s stock valued at $3,170,000 after buying an additional 64,081 shares during the last quarter. Institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.